EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Comparison of the Long‐Term Efficacy of Targeting the Subthalamic Nucleus Versus the Globus Pallidus Interna for Deep Brain Stimulation Treatment of Motor Dysfunction in Patients With Parkinson’s Disease: A Meta‐Analysis Study

Makenna Huhn iD, Matthew Prewett iD, Julien Rossignol iD, Gary L Dunbar iD

Parkinson's Disease · 2024-01 · 2024 (1)

DOI: 10.1155/padi/5157873 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Parkinson's Disease, online erschienen am 26.11.2024. Verfasst von Makenna Huhn und 3 weiteren Autor:innen. Beteiligte Einrichtung: Program in Neuroscience, Central Michigan University, Mount Pleasant 48859, Michigan, USA. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Central Michigan University.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A cardinal symptom of Parkinson’s disease (PD) is motor dysfunction, including bradykinesia and tremors, which is quantified in the Unified PD Rating Scale (UPDRS). Although some medications provide palliative treatments for these motor deficits, their efficacy wanes and can produce unwanted side effects, such as dyskinesia. Deep‐brain stimulation (DBS) has provided an alternative treatment strategy that can benefit many patients, but optimal target structures for DBS and its long‐term efficacy are not fully understood. The present study represents a meta‐analysis of the long‐term (> 5 years) effects of DBS on the two most common targets, the subthalamic nucleus (STN) and the globus pallidus interna (GPi), on scores of motor performance using the UPDRS‐III. The initial search of PubMed, Cochrane Library, and Clinical Trials resulted in 197 articles, of which 28 met the criteria for our analysis. Of the 1321 patients included, 1179 received STN DBS group and 142 received GPi DBS. UPDRS‐III scores for both target groups were analyzed at baseline and at either 5–8 or 10–15 years later for both on‐ and off‐medication phases. The results indicated that the STN stimulation is effective at reducing motor symptoms during off‐medication treatment for up to 15 years and that the GPi stimulation can be effective for up to at least 8 years. Our findings further suggest that STN‐ and GPi‐targeted DBS may wear off during the on‐medication phase between 5 and 10 years of treatment. This study supports findings that both DBSs of either the STN or GPi have long‐term efficacy, especially during off‐medication periods.

Autor:innen und Institutionen

  • Program in Neuroscience, Central Michigan University, Mount Pleasant 48859, Michigan, USA.
  • College of Medicine, Central Michigan University, Mount Pleasant 48859, Michigan, USA.
  • Department of Psychology, Central Michigan University, Mount Pleasant 48859, Michigan, USA.

ORCID-Profile: Makenna Huhn, Matthew Prewett, Julien Rossignol, Gary L Dunbar

Förderung

  • Central Michigan University

Zitieren

APA

Huhn, M., Prewett, M., Rossignol, J., & Dunbar, G. L. (2024). Comparison of the Long‐Term Efficacy of Targeting the Subthalamic Nucleus Versus the Globus Pallidus Interna for Deep Brain Stimulation Treatment of Motor Dysfunction in Patients With Parkinson’s Disease: A Meta‐Analysis Study. Parkinson's Disease, 2024(1). https://doi.org/10.1155/padi/5157873

Vancouver

Huhn M, Prewett M, Rossignol J, Dunbar GL. Comparison of the Long‐Term Efficacy of Targeting the Subthalamic Nucleus Versus the Globus Pallidus Interna for Deep Brain Stimulation Treatment of Motor Dysfunction in Patients With Parkinson’s Disease: A Meta‐Analysis Study. Parkinson's Disease. 2024;2024(1). doi:10.1155/padi/5157873

BibTeX
@article{Huhn2024,
  author = {Huhn, Makenna and Prewett, Matthew and Rossignol, Julien and Dunbar, Gary L},
  title = {Comparison of the Long‐Term Efficacy of Targeting the Subthalamic Nucleus Versus the Globus Pallidus Interna for Deep Brain Stimulation Treatment of Motor Dysfunction in Patients With Parkinson’s Disease: A Meta‐Analysis Study},
  journal = {Parkinson's Disease},
  year = {2024},
  volume = {2024},
  number = {1},
  doi = {10.1155/padi/5157873}
}
Kostenlos starten →